Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been given a consensus recommendation of “Hold” by the eight analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating on […]
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have been given a consensus recommendation of “Hold” by the eight analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating on […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}
